Partnering
Aeviant is open to conversations with scientists, research organizations and funding partners whose capabilities align with state-dependent therapeutic design and development.
An initial enquiry should identify the organization, the relevant capability or funding, and the proposed scope. Initial messages must remain non-confidential. Enquiries may also be sent directly to [email protected].
Areas of interest
Aeviant’s internal work currently centres on scientific strategy, target characterization, molecular design and computational analysis. Aeviant seeks collaborators who can extend defined program questions into medicinal chemistry, synthesis, functional assays, electrophysiology, in vivo pharmacology or scaled compute.
Relevant discussions may also involve GPCR pharmacology, receptor-state biology, assay development, molecular modelling, translational neuroscience, academic collaboration or non-dilutive support tied to a defined research or development scope.
Confidentiality
Technical discussion beyond the public information on this website requires a signed non-disclosure agreement. Initial enquiries must remain non-confidential and should not include unpublished mechanisms, structures, chemical information, experimental plans or other proprietary material.